CVA Family Office’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-23
| Closed | -$410 | – | 1399 |
|
|
2025
Q1 | $410 | Buy |
+23
| New | +$410 | ﹤0.01% | 1358 |
|
|
2022
Q3 | – | Sell |
-30
| Closed | -$2K | – | 911 |
|
|
2022
Q2 | $2K | Buy |
+30
| New | +$2K | ﹤0.01% | 834 |
|
|
2022
Q1 | – | Sell |
-45
| Closed | -$3K | – | 978 |
|
|
2021
Q4 | $3K | Buy |
+45
| New | +$3K | ﹤0.01% | 810 |
|